Prague Med. Rep. 2023, 124, 435-443
https://doi.org/10.14712/23362936.2023.33
A Practical and Applicable New Index as an Indicator of Inflammation in the Diagnosis of Erectile Dysfunction: C-reactive Protein-to-Albumin Ratio
References
1. 2020) Serum albumin and cardiovascular disease: State-of-the-art review. Ann. Cardiol. Angeiol. (Paris) 69(4), 192–200.
< , S. (https://doi.org/10.1016/j.ancard.2020.07.012>
2. 2022) C-reactive protein-albumin ratio and erectile dysfunction. Andrologia 27, e14386.
, S., Mikhailidis, D. P. (
3. 2007) Effects of CRP infusion on endothelial function and coagulation in normocholesterolemic and hypercholesterolemic subjects. J. Lipid Res. 48(4), 952–960.
< , R. J., Kastelein, J. J., Peters, S. L., Levels, J. H., Birjmohun, R., Rotmans, J. I., Hartman, D., Meijers, J. C., Levi, M., Stroes, E. S. (https://doi.org/10.1194/jlr.P600014-JLR200>
4. 2017) Critical appraisal of the role of serum albumin in cardiovascular disease. Biomark. Res. 5, 31.
< , S. C., Chen, C. Y., Lin, C. F., Yeh, H. I. (https://doi.org/10.1186/s40364-017-0111-x>
5. 2018) Stage effect of chronic kidney disease in erectile function. Int. Braz. J. Urol. 44(1), 132–140.
< , M. R., Ponciano, V. C., Costa, T. R., Gomes, C. P., de Oliveira, E. C. (https://doi.org/10.1590/s1677-5538.ibju.2017.0228>
6. 2018) Testosterone meets albumin – The molecular mechanism of sex hormone transport by serum albumins. Chem. Sci. 10(6), 1607–1618.
< , M. P., Venkataramany, B. S., Majorek, K. A., Handing, K. B., Porebski, P. J., Beeram, S. R., Suh, K., Woolfork, A. G., Hage, D. S., Shabalin, I. G., Minor, W. (https://doi.org/10.1039/C8SC04397C>
7. 2021) An independent indicator of erectile dysfunction is C-reactive protein/albumin ratio. Andrologia 53(7), e14073.
, S., Barlas, İ. Ş. (
8. 2004) Effect of C-reactive protein on chemokine expression in human aortic endothelial cells. J. Mol. Cell. Cardiol. 36(3), 405–410.
< , S., Kumaresan, P. R., Jialal, I. (https://doi.org/10.1016/j.yjmcc.2003.12.005>
9. 2016) Association between erectile function and biomarkers of subclinical atherosclerosis: A study based on middle-aged healthy men from the general population. Curr. Urol. 9(3), 119–123.
< , S., Rezanezhad, B., Willenheimer, R., Borgquist, R. (https://doi.org/10.1159/000442865>
10. 2007) ED2: Erectile dysfunction = Endothelial dysfunction. Endocrinol. Metab. Clin. North Am. 36(2), 453–463.
< , A. T. (https://doi.org/10.1016/j.ecl.2007.03.007>
11. Gulhar, R., Ashraf, M. A., Jialal, I. (2022) Physiology, Acute Phase Reactants. StatPearls [Internet].
12. 2021) C-reactive protein: More than a biomarker. J. Innate Immun. 13(5), 257–258.
< , H., Egesten, A. (https://doi.org/10.1159/000519091>
13. 2015) Erectile dysfunction in patients with liver disease related to chronic hepatitis B. Clin. Mol. Hepatol. 21(4), 352–357.
< , M., Kim, S. Y., Rou, W. S., Hwang, S. W., Lee, B. S. (https://doi.org/10.3350/cmh.2015.21.4.352>
14. 2021) Predominant factors affecting sexual dysfunction on patients with continuous ambulatory peritoneal dialysis. Maced. J. Med. Sci. 9(B), 373–377.
< , Y., Yetti, K., Made Kariasa, M. (https://doi.org/10.3889/oamjms.2021.6090>
15. 2019) Association between serum high-sensitivity C-reactive protein levels and erectile dysfunction: A cross-sectional study of Chinese male population. Sci. Rep. 9(1), 5929.
< , W., Chen, K., Zhang, J., Wang, X., Xu, G., Zhu, Y., Lv, Y. (https://doi.org/10.1038/s41598-019-42342-3>
16. 2006) Sexual function and quality of life in hemodialysis male patients. Nefrologia 26(4), 452–460. (in Spanish)
, F., Reig-Ferrer, A., Ferrer-Cascales, R. (
17. 2017) Immunoanalytical characteristics of C-reactive protein and high sensitivity C-reactive protein. Ann. Biol. Clin. (Paris) 75(2), 225–229.
, M., Lamrani Hanchi, A., Baraou, A., Boukhira, A., Chellak, S. (
18. 2019) Assessment of the relationship between preprocedural C-reactive protein/albumin ratio and stent restenosis in patients with ST-segment elevation myocardial infarction. Rev. Port. Cardiol. (Engl. Ed.) 38(4), 269–277. (in English, Portuguese)
< , I., Karabağ, Y., Çağdaş, M., Karakoyun, S., Seyis, S., Gürsoy, M. O., Yesin, M., Artaç, İ., İliş, D., Tanboğa, İ. H. (https://doi.org/10.1016/j.repc.2018.08.008>
19. 1993) The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 362(6423), 801–809.
< , R. (https://doi.org/10.1038/362801a0>
20. 2018) Prognostic significance of the preoperative ratio of C-reactive protein to albumin and neutrophil-lymphocyte ratio in gastric cancer patients. World J. Surg. 42(6), 1819–1825.
< , H., Kono, Y., Murakami, Y., Shishido, Y., Kuroda, H., Matsunaga, T., Fukumoto, Y., Osaki, T., Ashida, K., Fujiwara, Y. (https://doi.org/10.1007/s00268-017-4400-1>
21. 2021) Anatomy, pathophysiology, molecular mechanisms, and clinical management of erectile dysfunction in patients affected by coronary artery disease: A review. Biomedicines 9(4), 432.
< , G., Cereda, A., Benedetto, D., Bonanni, M., Chiricolo, G., Cota, L., Martuscelli, E., Greco, F. (https://doi.org/10.3390/biomedicines9040432>
22. 2016) The correlation between highly sensitive C-reactive protein levels and erectile function among men with late-onset hypogonadism. Aging Male 19(4), 239–243.
< , K., Konaka, H., Ijima, M., Nohara, T., Narimoto, K., Izumi, K., Kadono, Y., Kitagawa, Y., Mizokami, A., Namiki, M. (https://doi.org/10.1080/13685538.2016.1233960>
23. Sooriyamoorthy, T., Leslie, S. W. (2022) Erectile Dysfunction. StatPearls [Internet].
24. 2007) Erectile dysfunction predicts generalised cardiovascular disease: Evidence from a case-control study. Atherosclerosis 194(2), 458–464.
< , B. G., Walsh, J. P., Ching, H. L., Stuckey, A. W., Palmer, N. R., Thompson, P. L., Watts, G. F. (https://doi.org/10.1016/j.atherosclerosis.2006.08.043>
25. 2005) Erectile dysfunction in patients with chronic viral liver disease: Its relevance to protein malnutrition. J. Gastroenterol. 40(9), 894–900.
< , K., Miwa, Y., Kuriyama, S., Fukushima, H., Shiraki, M., Murakami, N., Shimazaki, M., Ito, Y., Nakamura, T., Sugihara, J., Tomita, E., Nagata, C., Suzuki, K., Moriwaki, H. (https://doi.org/10.1007/s00535-005-1634-8>
26. 2014) Albumin administration in the acutely ill: What is new and where next? Crit. Care 18(4), 231.
< , J. L., Russell, J. A., Jacob, M., Martin, G., Guidet, B., Wernerman, J., Ferrer, R., McCluskey, S. A., Gattinoni, L. (https://doi.org/10.1186/cc13991>
27. 2008) The triad: Erectile dysfunction – Endothelial dysfunction – Cardiovascular disease. Curr. Pharm. Des. 14(35), 3700–3714.
< , C., Ioakeimidis, N., Terentes-Printzios, D., Stefanadis, C. (https://doi.org/10.2174/138161208786898716>
28. 2016) Erectile dysfunction. Nat. Rev. Dis. Primers 2, 16003.
< , F. A., Jenkins, L., Albersen, M., Corona, G., Isidori, A. M., Goldfarb, S., Maggi, M., Nelson, C. J., Parish, S., Salonia, A., Tan, R., Mulhall, J. P., Hellstrom, W. J. (https://doi.org/10.1038/nrdp.2016.3>
29. 2010) Cardiovascular and metabolic syndrome risk among men with and without erectile dysfunction: Case-control study. Sao Paulo Med. J. 128(3), 137–140.
< , J. P., Mendonça, R. R., Wroclawski, M. L., Karam Junior, A., Santos, R. D., Carvalho, J. A., Wroclawski, E. R. (https://doi.org/10.1590/S1516-31802010000300006>
30. 2019) Erectile dysfunction predicts cardiovascular events as an independent risk factor: A systematic review and meta-analysis. J. Sex. Med. 16(7), 1005–1017.
< , B., Hong, Z., Wei, Y., Yu, D., Xu, J., Zhang, W. (https://doi.org/10.1016/j.jsxm.2019.04.004>